Mark Hatley, MD, PhD

    Mark E. Hatley, MD, PhD

    Assistant Member, St. Jude Faculty

    Departments

    Oncology

    Divisions

    Solid Tumor

    Contact Information

    Mark Hatley, MD, PhD
    Solid Tumor
    MS 310, Room D5024F
    St. Jude Children's Research Hospital
    262 Danny Thomas Place
    Memphis, TN 38105-3678
    Email: mark.hatley@stjude.org
    FAX: (901) 595-3966

    Education

    BS – University of Central Oklahoma, Edmond, Oklahoma
    MD, PhD – University of Texas Southwestern Medical Center at Dallas, Medical Scientist Training Program, Dallas, Texas


    Research Interests


    Selected Publications

    Hatley ME, Tang W, Garcia MR, Finkelstein D, Millay DP, Liu N, Graff J, Galindo RL, Olson EN. A mouse model of rhabdomyosarcoma originating from the adipocyte lineage. Cancer Cell 16:536-46, 2012. PMCID: PMC3479681

    Hatley ME, Patrick DM, Garcia MR, Ricardson JA, Bassel-Duby R, van Rooij, Olson EN. Modulation of K-ras-dependent lung tumorigenesis by microRNA-21. Cancer Cell 18:282-93, 2010. PMCID: PMC2971666.

    Hatley ME, Lockless SW, Gibson SK, Gilman AG, Ranganathan R. Allosteric determinants of guanine nucleotide binding proteins. Proceedings of the National Academy of Science 100:14445-50, 2003.

    Hatley ME, Gilman AG, Sunahara RK. Expression, purification, and assay of cytosolic (catalytic) domains of membrane-bound mammalian adenylyl cyclases. Methods in Enzymology 345:127-40, 2002.

    Hatley ME, Benton BK, Xu J, Manfredi JP, Gilman AG, Sunahara RK. Isolation and characterization of constitutively active mutants of mammalian adenylyl cyclase. Journal Biological Chemistry 275(49):38626-32, 2000.

    O’Hair RAJ, Freitas MA, Schmidt JAR, Hatley ME, Williams TD. Gas-phase methylation fo 2-hydroxypyridine/2-pyridone system by the dimethylchloronium ion. European Mass Spectrometry 1:457-463,1995.

    Last update: February 2013